How Smoking Affects a New Drug in Postmenopausal Women
This study tests how a new experimental drug (GS1-144) moves through the body differently in women who smoke versus those who don't. Researchers want to understand if smoking changes how the drug works, which could help doctors prescribe the right dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a postmenopausal woman aged 40–65 (no menstrual periods for at least 6 months, or had ovary surgery)
- Weigh at least 45 kg and have a healthy weight range (BMI 18–28)
- Be either a current smoker (10+ cigarettes daily for 6 months) or a non-smoker (none for 6 months)
- Have no serious health conditions, allergies, or current medications that could interfere with the study
- Pass blood tests showing normal liver and kidney function, and test negative for HIV and hepatitis
- Be willing to have blood drawn multiple times and follow strict rules about food, drinks, and other medications during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how safe and tolerable a new drug, KSHN001034, is in healthy women who have gone through menopause. It involves multiple doses to see how your body processes the medicine.
This study tests the safety of a new medicine called IMC-003. It is for healthy women who have gone through menopause. You may be able to join if you are between 45 and 75 years old and meet certain health criteria.
This study tests how food affects the body's processing of an investigational drug (HS-10518) in healthy premenopausal women. The goal is to see if taking the drug with or without food changes its levels, which helps decide how to take it in future studies.
This study looks at how temporarily stopping ovarian function affects weight, body fat, and blood vessel health in premenopausal women. If you qualify, you might help researchers understand the risks and benefits of short-term estrogen suppression.
This study tests whether a new medication (CL25216) can help reduce hot flashes and other menopause symptoms in women going through perimenopause. It is specifically for overweight women who are still having irregular periods.
This trial tests a drug called GS1-144 in women with mild to moderate liver problems and in healthy women. It aims to see how the drug works differently based on liver function.
Hear when a new Postmenopause trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.